Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Canobbio

Showing results (21-30 of 40) with videos related to

Pageof 4
Sort By:
Oncology|March 5, 2011
Prognostic value of estrogen receptor and Ki-67 index after neoadjuvant chemotherapy in locally advanced breast cancer expressing high levels of proliferation at diagnosisL Miglietta, P Vanella, L Canobbio, et al.
International Journal of Clinical Pharmacology, Therapy, and Toxicology|February 1, 1987
Combination of amikacin and ceftazidime as empiric treatment of febrile leukopenic patients affected by solid tumorsG Gasparini, M Benedetti, T Fassio, et al.
Anticancer Research|January 1, 1996
Combination therapy with subcutaneous interleukin-2 and interferon-alpha in advanced renal cancer patients with poor prognostic factorsL Canobbio, A Curotto, D Cannata, et al.
Cancer Investigation|January 1, 1988
Phase II trial of oral idarubicin in advanced non-small cell lung cancer (NSCLC)A Ardizzoni, P Pronzato, L Repetto, et al.
Breast Cancer Research and Treatment|November 1, 1987
Alternating tamoxifen and medroxyprogesterone acetate in postmenopausal advanced breast cancer patients--short and long term endocrine effectsL Canobbio, E Galligioni, G Gasparini, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|July 30, 2013
A prognostic model based on combining estrogen receptor expression and Ki-67 value after neoadjuvant chemotherapy predicts clinical outcome in locally advanced breast cancer: extension and analysis of a previously reported cohort of patientsL Miglietta, F Morabito, N Provinciali, et al.
Cancer|September 1, 1986
Hypercoagulable state induced by cytostatic drugs in stage II breast cancer patientsL Canobbio, T Fassio, A Ardizzoni, et al.
Chemioterapia : International Journal of the Mediterranean Society of Chemotherapy|December 1, 1986
Adriamycin, cyclophosphamide and etoposide (ACE) in the treatment of small cell lung cancerA Ardizzoni, L Canobbio, P Pronzato, et al.
European Journal of Cancer & Clinical Oncology|June 1, 1987
Cisplatin and 5-fluorouracil combination chemotherapy in advanced and/or metastatic colorectal carcinoma: a phase II studyE Galligioni, L Canobbio, F Figoli, et al.
Cancer Investigation|January 1, 1988
Cisplatin and etoposide as second-line chemotherapy in patients with small cell lung cancerF Figoli, A Veronesi, A Ardizzoni, et al.
Pageof 4

Showing results (21-30 of 40) with videos related to

Sort By:
Pageof 4
Oncology|March 5, 2011
Prognostic value of estrogen receptor and Ki-67 index after neoadjuvant chemotherapy in locally advanced breast cancer expressing high levels of proliferation at diagnosisL Miglietta, P Vanella, L Canobbio, et al.
International Journal of Clinical Pharmacology, Therapy, and Toxicology|February 1, 1987
Combination of amikacin and ceftazidime as empiric treatment of febrile leukopenic patients affected by solid tumorsG Gasparini, M Benedetti, T Fassio, et al.
Anticancer Research|January 1, 1996
Combination therapy with subcutaneous interleukin-2 and interferon-alpha in advanced renal cancer patients with poor prognostic factorsL Canobbio, A Curotto, D Cannata, et al.
Cancer Investigation|January 1, 1988
Phase II trial of oral idarubicin in advanced non-small cell lung cancer (NSCLC)A Ardizzoni, P Pronzato, L Repetto, et al.
Breast Cancer Research and Treatment|November 1, 1987
Alternating tamoxifen and medroxyprogesterone acetate in postmenopausal advanced breast cancer patients--short and long term endocrine effectsL Canobbio, E Galligioni, G Gasparini, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|July 30, 2013
A prognostic model based on combining estrogen receptor expression and Ki-67 value after neoadjuvant chemotherapy predicts clinical outcome in locally advanced breast cancer: extension and analysis of a previously reported cohort of patientsL Miglietta, F Morabito, N Provinciali, et al.
Cancer|September 1, 1986
Hypercoagulable state induced by cytostatic drugs in stage II breast cancer patientsL Canobbio, T Fassio, A Ardizzoni, et al.
Chemioterapia : International Journal of the Mediterranean Society of Chemotherapy|December 1, 1986
Adriamycin, cyclophosphamide and etoposide (ACE) in the treatment of small cell lung cancerA Ardizzoni, L Canobbio, P Pronzato, et al.
European Journal of Cancer & Clinical Oncology|June 1, 1987
Cisplatin and 5-fluorouracil combination chemotherapy in advanced and/or metastatic colorectal carcinoma: a phase II studyE Galligioni, L Canobbio, F Figoli, et al.
Cancer Investigation|January 1, 1988
Cisplatin and etoposide as second-line chemotherapy in patients with small cell lung cancerF Figoli, A Veronesi, A Ardizzoni, et al.
Pageof 4